Researchers have developed a novel cancer treatment approach using a synthetic “mirror-image” molecule of serine, a key amino acid. This molecule, known as D-serine, is chemically identical to the natural L-serine but has a reversed spatial structure. Cancer cells, which are heavily dependent on serine to fuel their rapid growth, mistakenly take up the D-serine. However, they cannot metabolize it, effectively starving the cancer cells of this critical nutrient and halting their proliferation. Crucially, healthy cells can distinguish between the two forms and continue using natural serine, minimizing damage to normal tissues. This targeted method represents a promising new strategy in oncology that could lead to more selective and less toxic therapies. Read the full article at: https://www.sciencedaily.com/releases/2026/03/260311213453.htm